In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
395 News Items found
Scientists at the Sloan Kettering Institute are learning why some immune cells are stubbornly hard to revive with immunotherapy.
In the Lab
Why Immune Cells Sometimes Fail to Fight Cancer (and What to Do about It)

By looking at how DNA is packaged in cells, scientists are teasing apart a long-standing conundrum about the immune response to cancer.
Francis M. Sirotnak
FDA Approves Lymphoma Drug Developed at Memorial Sloan Kettering

Patients with a rare but aggressive form of cancer now have access to a drug that has proven effective after the disease becomes resistant to standard treatments.
Dennis Flaherty
Feature
How MSK Is Helping Dennis Survive Stage 4 Kidney Cancer

When Dennis Flaherty was diagnosed with stage 4 kidney cancer, he knew he wanted to be treated at MSK. His story illustrates why U.S. News & World Report ranked MSK the top hospital in the country for urology care in 2023.
Pictured: David Solit
Profile
At Work: Physician-Scientist David Solit

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.
Four dogs wearing blue bandanas are held on leashes in a hallway at Memorial Hospital. Three handlers are seen only from the waist down.
Feature
Top Dogs: Meet MSK’s Four-Legged Volunteers

The Caring Canines program at Memorial Sloan Kettering has been going strong for more than 12 years.
an illustration of a cigarette burning and smoke entering lungs
Feature
How Do Cigarettes Cause Cancer?

Everyone knows that cigarettes cause cancer. But what do we know about how they do it?
Giovanna Whitting
For Thyroid Cancers with RET Mutations, FDA Approves Selpercatinib

The FDA has granted full approval to the targeted therapy selpercatinib (Retevmo®) for treating thyroid cancers that have certain changes in a gene called RET. Learn about MSK’s role in the development of this drug and about how patients may benefit.
Joan Massagué
How Cancer Spreads: Four Emerging Insights About Metastasis

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.
MSK helped Roberto Romero’s immune system grow an army of T cells to fight melanoma using TIL therapy, which offers new hope against solid tumors.
How MSK Used TIL Therapy To Treat Melanoma in Roberto

Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.
AACR sign
At AACR, MSK Researchers Spotlight Health Disparities and Propose Solutions

Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses.